| 【Company Research】Xpeng Inc. (XPEV US/9868 HK) - New models, robots, robotaxi as key catalysts |
| 【Company Research】Salesforce (CRM US) - 1QFY27 review: solid Agentforce growth; accelerating capital return |
| 【Company Research】CSPC Pharmaceutical (1093 HK) - Core sales inflection with substantial BD optionality |
| 【Company Research】PDD Holdings (PDD US) - Investing to enhance supply chain capabilities |
| 【Company Research】Kuaishou (1024 HK) - 1Q26 review: Kling AI maintained strong monetization momentum |
| 【Company Research】3SBio (1530 HK) - ASCO 2026 takeaways: encouraging first mPFS readout for 707 in 1L PD-L1+ NSCLC |
| 【Sector Research】China Insurance - 1Q26 insurance funds: Core equities sustained mid-teens share; Life core solvency rebounded |
| 【Company Research】Tongcheng Travel (780 HK) - 1Q26 results beat; higher oil prices dampen short-term revenue growth outlook |
| 【Company Research】NIO Inc. (NIO US/9866 HK) - Historical detractors appear resolved |
| 【Company Research】NetEase (NTES US) - 1Q26 results: strong profit beat on margin expansion; solid game pipeline in 2H26E |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
